Drugs for Xanthomatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 14)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
chenodeoxycholic acid |
Approved |
Phase 3 |
|
474-25-9 |
10133 |
Synonyms:
(+)-Chenodeoxycholate
(+)-Chenodeoxycholic acid
(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oate
(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oic acid
3a,7a-Dihydroxy-5b,14a,17b-cholanate
3a,7a-Dihydroxy-5b,14a,17b-cholanic acid
3a,7a-Dihydroxy-5b-cholan-24-Oate
3a,7a-Dihydroxy-5b-cholan-24-Oic acid
3a,7a-Dihydroxy-5b-cholanate
3a,7a-Dihydroxy-5b-cholanic acid
3alpha,7alpha-Dihydroxy-5beta-cholanate
3alpha,7alpha-Dihydroxy-5beta-cholanic acid
3α,7α-dihydroxy-5β-cholanate
3α,7α-dihydroxy-5β-cholanic acid
7a-Hydroxy-desoxycholsaeure
7a-Hydroxylithocholate
7a-Hydroxylithocholic acid
7alpha-Hydroxylithocholate
7alpha-Hydroxylithocholic acid
7α-hydroxylithocholate
7α-hydroxylithocholic acid
Acid, chenic
Acid, chenique
Acid, chenodeoxycholic
Acid, gallodesoxycholic
Acide chenodeoxycholique
Acido chenodeoxicholico
Acidum chenodeoxycholicum
Anthropodeoxycholate
|
Anthropodeoxycholic acid
Anthropodesoxycholate
Anthropodesoxycholic acid
Antigen brand OF chenodeoxycholic acid
CDCA
Chenate
Chenic acid
Chenique acid
Chenix
Chenocholic acid
Chenodeoxycholate
Chenodeoxycholate, sodium
Chenodeoxycholic acid
Chenodesoxycholic acid
Chenodesoxycholsaeure
Chenodiol
Chenofalk
Chenophalk
Estedi brand OF chenodeoxycholic acid
Falk brand OF chenodeoxycholic acid
Gallodesoxycholate
Gallodesoxycholic acid
Henohol
Quenobilan
Quenocol
Sodium chenodeoxycholate
Solvay brand OF chenodeoxycholic acid
tramedico Brand OF chenodeoxycholic acid
Zambon brand OF chenodeoxycholic acid
|
|
2 |
|
tannic acid |
Approved |
Phase 3 |
|
1401-55-4 |
|
Synonyms:
ácido tánico
Gallotannic acid
|
|
|
3 |
|
Benzocaine |
Approved, Investigational |
Phase 3 |
|
94-09-7, 1994-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
|
Ethyl aminobenzoic acid
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
4 |
|
Cathartics |
|
Phase 3 |
|
|
|
5 |
|
Gastrointestinal Agents |
|
Phase 3 |
|
|
|
6 |
|
Laxatives |
|
Phase 3 |
|
|
|
7 |
|
Lovastatin |
Approved, Investigational |
Phase 2 |
|
75330-75-5 |
53232 |
Synonyms:
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyric acid
1 alpha-Isomer lovastatin
1cqp
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinate lactone
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinate lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2β,6α-dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinate lactone
2β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinic acid lactone
6 alpha-Methylcompactin
6 Methylcompactin
6alpha-methylcompactin
6-alpha-methylcompactin
6alpha-Methylcompactin
6-alpha-Methylcompactin
6a-Methylcompactin
6-Methylcompactin
6α-methylcompactin
71949-96-7
74133-25-8
75330-75-5
81739-26-6
AC-13961
AC1L1EI6
AC1Q2C7T
ACon0_000534
ACon1_000390
alpha-Isomer lovastatin, 1
Altocor
Altoprev
ARONIS24208
Artein
BB_NC-1457
Belvas
BIDD:GT0749
BIDD:PXR0113
BPBio1_000519
BRD-K09416995-001-06-8
BRN 3631989
BSPBio_000471
BSPBio_001265
BSPBio_003346
C07074
C24H36O5
CCRIS 8092
CHEBI:40303
CHEMBL503
Cholestra
CID53232
Closterol
Colevix
CPD000673570
CPD-5561
D00359
D008148
DB00227
DivK1c_001032
Hipolip
Hipovastin
HMS1569H13
HMS1792O07
HMS1923O13
HMS1990O07
HMS2089M06
HMS2093O03
HMS503O05
HSDB 6534
I06-1876
IDI1_001032
KBio1_001032
KBio3_002848
L0214
L-154803
Lestatin
Lipdip
Lipivas
|
Lipofren
Liposcler
Lovalip
Lovalord
lovastatin
Lovastatin
Lovastatin & Primycin
Lovastatin (USP/INN)
Lovastatin [USAN:BAN:INN]
lovastatin lactone
Lovastatin, (1 alpha(s*))-isomer
Lovastatin, (1 alpha(S*))-Isomer
Lovastatin, 1 alpha isomer
Lovastatin, 1 alpha-isomer
Lovastatin, 1 alpha-Isomer (without R*/S* notation)
Lovastatina
Lovastatina [Spanish]
Lovastatine
Lovastatine [French]
Lovastatinum
Lovastatinum [Latin]
Lovasterol
Lovastin
Lozutin
LS-46359
M2147_SIGMA
MEGxm0_000398
Mevacor
Mevacor (TN)
Mevinacor
Mevinolin
Mevinolin from Aspergillus sp.
Mevlor
MK 803
MK803
MK-803
ML-530b
ML-530B
MLS000069585
MLS001055358
MolPort-001-739-990
Monacolin K
Monacolin-K
Monakolin K
MSD 803
NCGC00023509-03
NCGC00023509-04
NCGC00023509-05
NCGC00023509-06
NCGC00023509-07
NCGC00023509-08
nchembio742-comp5
nchembio790-comp14
nchembio869-comp12
Nergadan
NINDS_001032
Paschol
Prestwick_819
Prestwick0_000516
Prestwick1_000516
Prestwick2_000516
Prestwick3_000516
Rextat
Rodatin
Rovacor
SAM002589963
Sivlor
SMR000058779
SMR000673570
SPBio_002392
SPECTRUM1503977
Spectrum3_001873
Spectrum5_001294
STK801953
Taucor
Tecnolip
Teroltrat
UNII-9LHU78OQFD
ZINC03812841
|
|
8 |
|
Dihydromevinolin |
|
Phase 2 |
|
|
|
9 |
|
Lipid Regulating Agents |
|
Phase 2 |
|
|
|
10 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 2 |
|
|
|
11 |
|
Anticholesteremic Agents |
|
Phase 2 |
|
|
|
12 |
|
Antimetabolites |
|
Phase 2 |
|
|
|
13 |
|
Hypolipidemic Agents |
|
Phase 2 |
|
|
|
14 |
|
L 647318 |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show all 11)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Phase 3 Study to Evaluate the Effects of Chenodeoxycholic Acid in Adult and Pediatric Patients With Cerebrotendinous Xanthomatosis |
Recruiting |
NCT04270682 |
Phase 3 |
Blinded CDCA 250 mg TID;Placebo;Open-Label CDCA 250 mg TID;Rescue Medication CDCA 250 mg TID;CDCA Weight-Based Dose TID |
2 |
Effects of Diet and Medication in Patients With Cerebrotendinous Xanthomatosis (CTX) |
Unknown status |
NCT00004346 |
Phase 2 |
chenodeoxycholic acid;lovastatin |
3 |
Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis |
Unknown status |
NCT01613898 |
|
|
4 |
Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia |
Completed |
NCT02462655 |
|
|
5 |
Relationships Between Lipoprotein(a) Levels and Aortic Valve Calcification in Patients With Heterozygous Familial Hypercholesterolemia |
Completed |
NCT02976818 |
|
|
6 |
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts |
Recruiting |
NCT02638220 |
|
|
7 |
An Observational Study With Retrospective and Prospective Evaluations to Determine the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disorder in Juvenile Cataract Cases in Turkey |
Recruiting |
NCT03584893 |
|
|
8 |
International Rare Histiocytic Disorders Registry (IRHDR) |
Recruiting |
NCT02285582 |
|
|
9 |
A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX) in Families With Kinship Bonds and at Least One Homozygous Patient |
Enrolling by invitation |
NCT04218006 |
|
|
10 |
An Epidemiological Observational Study for Retrospective and Prospective Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease in Neurology and Pediatric Metabolism Clinics in Turkey |
Not yet recruiting |
NCT04113083 |
|
|
11 |
Biologic Significance of Cholestanol in Man |
Withdrawn |
NCT00018694 |
|
Chenodeoxycholic Acid |
Cochrane evidence based reviews: xanthomatosis
|